These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16945924)

  • 1. Azumolene inhibits a component of store-operated calcium entry coupled to the skeletal muscle ryanodine receptor.
    Zhao X; Weisleder N; Han X; Pan Z; Parness J; Brotto M; Ma J
    J Biol Chem; 2006 Nov; 281(44):33477-86. PubMed ID: 16945924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of azumolene on Ca2+ sparks in skeletal muscle fibers.
    Zhang Y; Rodney GG; Schneider MF
    J Pharmacol Exp Ther; 2005 Jul; 314(1):94-102. PubMed ID: 15831441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased store-operated Ca2+ entry in skeletal muscle with reduced calsequestrin-1 expression.
    Zhao X; Min CK; Ko JK; Parness J; Kim DH; Weisleder N; Ma J
    Biophys J; 2010 Sep; 99(5):1556-64. PubMed ID: 20816068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformation of ryanodine receptor-2 gates store-operated calcium entry in rat pulmonary arterial myocytes.
    Lin AH; Sun H; Paudel O; Lin MJ; Sham JS
    Cardiovasc Res; 2016 Jul; 111(1):94-104. PubMed ID: 27013634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated activation of SOCE current in myotubes from two mouse models of anesthetic- and heat-induced sudden death.
    Yarotskyy V; Protasi F; Dirksen RT
    PLoS One; 2013; 8(10):e77633. PubMed ID: 24143248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors.
    Fruen BR; Mickelson JR; Louis CF
    J Biol Chem; 1997 Oct; 272(43):26965-71. PubMed ID: 9341133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of azumolene on doxorubicin-induced Ca2+ release from skeletal and cardiac muscle sarcoplasmic reticulum.
    Tian Q; Katz AM; Kim DH
    Biochim Biophys Acta; 1991 Aug; 1094(1):27-34. PubMed ID: 1883852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of dantrolene binding sites in porcine skeletal muscle sarcoplasmic reticulum.
    Parness J; Palnitkar SS
    J Biol Chem; 1995 Aug; 270(31):18465-72. PubMed ID: 7629173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dantrolene and azumolene inhibit [3H]PN200-110 binding to porcine skeletal muscle dihydropyridine receptors.
    el-Hayek R; Parness J; Valdivia HH; Coronado R; Hogan K
    Biochem Biophys Res Commun; 1992 Sep; 187(2):894-900. PubMed ID: 1326958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halothane modulation of skeletal muscle ryanodine receptors: dependence on Ca2+, Mg2+, and ATP.
    Diaz-Sylvester PL; Porta M; Copello JA
    Am J Physiol Cell Physiol; 2008 Apr; 294(4):C1103-12. PubMed ID: 18305228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dantrolene-induced inhibition of skeletal L-type Ca2+ current requires RyR1 expression.
    Bannister RA
    Biomed Res Int; 2013; 2013():390493. PubMed ID: 23509717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.
    Sudo RT; Carmo PL; Trachez MM; Zapata-Sudo G
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):308-16. PubMed ID: 18047479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity.
    Zhao F; Li P; Chen SR; Louis CF; Fruen BR
    J Biol Chem; 2001 Apr; 276(17):13810-6. PubMed ID: 11278295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression levels of RyR1 and RyR3 control resting free Ca2+ in skeletal muscle.
    Perez CF; López JR; Allen PD
    Am J Physiol Cell Physiol; 2005 Mar; 288(3):C640-9. PubMed ID: 15548569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
    Roesl C; Sato K; Schiemann A; Pollock N; Stowell KM
    Cell Calcium; 2014 Sep; 56(3):195-201. PubMed ID: 25086907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor.
    Paul-Pletzer K; Yamamoto T; Bhat MB; Ma J; Ikemoto N; Jimenez LS; Morimoto H; Williams PG; Parness J
    J Biol Chem; 2002 Sep; 277(38):34918-23. PubMed ID: 12167662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR.
    Yang T; Esteve E; Pessah IN; Molinski TF; Allen PD; López JR
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1591-8. PubMed ID: 17182726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A central core disease mutation in the Ca
    Chirasani VR; Xu L; Addis HG; Pasek DA; Dokholyan NV; Meissner G; Yamaguchi N
    Am J Physiol Cell Physiol; 2019 Aug; 317(2):C358-C365. PubMed ID: 31166712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of azumolene on hypercontractility and sarcoplasmic reticulum Ca(2+)-dependent ATPase activity of malignant hyperpyrexia-susceptible porcine skeletal muscle.
    Foster PS; Hopkinson KC; Payne N; Denborough MA
    Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):489-95. PubMed ID: 1833102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a calcium-regulation domain of the skeletal-muscle ryanodine receptor.
    Hayek SM; Zhu X; Bhat MB; Zhao J; Takeshima H; Valdivia HH; Ma J
    Biochem J; 2000 Oct; 351(Pt 1):57-65. PubMed ID: 10998347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.